| Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ... The Lancet Oncology 19 (1), 27-39, 2018 | 970 | 2018 |
| Impact of breast surgery in primary metastasized breast cancer: outcomes of the prospective randomized phase III ABCSG-28 POSYTIVE trial F Fitzal, V Bjelic-Radisic, M Knauer, G Steger, M Hubalek, M Balic, ... Annals of surgery 269 (6), 1163-1169, 2019 | 176 | 2019 |
| Genetic variability of populations and similarity of subpopulations in Austrian cattle breeds determined by analysis of pedigrees J Sölkner, L Filipcic, N Hampshire Animal Science 67 (2), 249-256, 1998 | 136 | 1998 |
| Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian … PC Dubsky, R Jakesz, B Mlineritsch, S Pöstlberger, H Samonigg, ... Journal of Clinical Oncology 30 (7), 722-728, 2012 | 120 | 2012 |
| Duration of adjuvant aromatase-inhibitor therapy in postmenopausal breast cancer M Gnant, F Fitzal, G Rinnerthaler, GG Steger, S Greil-Ressler, M Balic, ... New England Journal of Medicine 385 (5), 395-405, 2021 | 119 | 2021 |
| Prognostic value of number of removed lymph nodes, number of involved lymph nodes, and lymph node ratio in 7502 breast cancer patients enrolled onto trials of the Austrian … C Tausch, S Taucher, P Dubsky, M Seifert, R Reitsamer, W Kwasny, ... Annals of surgical oncology 19, 1808-1817, 2012 | 72 | 2012 |
| Abstract GS3-01: A prospective randomized multi-center phase-III trial of additional 2 versus additional 5 years of anastrozole after initial 5 years of adjuvant endocrine … M Gnant, G Steger, R Greil, F Fitzal, B Mlineritsch, D Manfreda, C Tausch, ... Cancer Research 78 (4_Supplement), GS3-01-GS3-01, 2018 | 65 | 2018 |
| Anthracycline-containing and taxane-containing chemotherapy for early-stage operable breast cancer: a patient-level meta-analysis of 100 000 women from 86 randomised trials J Braybrooke, R Bradley, R Gray, RK Hills, H Pan, R Peto, D Dodwell, ... The Lancet 401 (10384), 1277-1292, 2023 | 50 | 2023 |
| Prospective validation of a lymphocyte infiltration prognostic test in stage III colon cancer patients treated with adjuvant FOLFOX JF Emile, C Julié, K Le Malicot, C Lepage, J Tabernero, E Mini, ... European journal of cancer 82, 16-24, 2017 | 45 | 2017 |
| Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive … V Bjelic-Radisic, F Fitzal, M Knauer, G Steger, D Egle, R Greil, P Schrenk, ... BMC cancer 20, 1-15, 2020 | 44 | 2020 |
| Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and … G Fastner, F Sedlmayer, J Widder, M Metz, H Geinitz, K Kapp, C Fesl, ... European Journal of Cancer 127, 12-20, 2020 | 29 | 2020 |
| Neoadjuvant chemotherapy with capecitabine, oxaliplatin and bevacizumab followed by concomitant chemoradiation and surgical resection in locally advanced rectal cancer with … W Eisterer, G Piringer, A De Vries, D Oefner, R Greil, J Tschmelitsch, ... Anticancer Research 37 (5), 2683-2691, 2017 | 15 | 2017 |
| Intensified preoperative chemoradiation by adding oxaliplatin in locally advanced, primary operable (cT3NxM0) rectal cancer: Impact on long-term outcome. Results of the phase … P Kogler, AF DeVries, W Eisterer, J Thaler, L Sölkner, D Öfner Strahlentherapie und Onkologie 194 (1), 41, 2018 | 10 | 2018 |
| Primary operation in synchroneous metastasized invasive breast cancer patients: first oncologic outcomes of the prospective randomized phase III ABCSG 28 POSYTIVE trial. F Fitzal, M Balic, V Bjelic-Radisic, M Hubalek, CF Singer, GG Steger, ... Journal of Clinical Oncology 35 (15_suppl), 557-557, 2017 | 9 | 2017 |
| Follicle stimulating hormone (FSH) as a surrogate parameter for the effectiveness of endocrine therapy with or without zoledronic acid in premenopausal patients with breast … G Pfeiler, R Königsberg, L Filipcic, R Greil, H Stoger, CF Singer, M Knauer, ... Journal of Clinical Oncology 32 (15_suppl), 577-577, 2014 | 6 | 2014 |
| Analiza genetske varijabilnosti hrvatskog simentalskog goveda pomoću pedigrea: analiza začetnika I Čurik, L Filipčić, J Soelkner 34. godišnji znanstveni skup hrvatskih agronoma, 299-299, 1998 | 5 | 1998 |
| Quality-of-life results from a randomized, phase-II-study of the therapeutic cancer vaccine L-BLP25 (Stimuvax (R)) in the preoperative treatment of women with primary breast … V Bjelic-Radisic, CF Singer, G Pfeiler, M Hubalek, R Bartsch, H Stoger, ... ANNALS OF ONCOLOGY 28, 2017 | 4 | 2017 |
| Does the number of 6-monthly adjuvant zoledronate infusions received affect treatment efficacy for early breast cancer? A sub-study of ABCSG-12 AA Beltran-Bless, MJ Clemons, C Fesl, R Greil, GR Pond, M Balic, ... European Journal of Cancer 180, 108-116, 2023 | 2 | 2023 |
| Development of a modular course system in Internet training Z Bekić, L Filipčić, M Milinović Nepoznat skup, 1998 | 2 | 1998 |
| LM02 trial Perioperative treatment with panitumumab and FOLFIRI in patients with wild-type RAS, potentially resectable colorectal cancer liver metastases—a phase II study G Piringer, T Gruenberger, J Thaler, I Kührer, K Kaczirek, F Längle, ... Frontiers in Oncology 13, 1231600, 2023 | 1 | 2023 |
Zoran BekićUniversity Computing Center (SRCE), University of ZagrebVerified email at srce.hr